Humana (NYSE:HUM) Stock Price Up 0.1%

Humana Inc. (NYSE:HUM)’s stock price shot up 0.1% on Monday . The company traded as high as $322.89 and last traded at $320.75. 336,794 shares traded hands during mid-day trading, a decline of 83% from the average session volume of 1,972,597 shares. The stock had previously closed at $320.54.

Analyst Ratings Changes

HUM has been the subject of several recent research reports. StockNews.com lowered shares of Humana from a “strong-buy” rating to a “hold” rating in a report on Friday, January 26th. Jefferies Financial Group lowered their target price on Humana from $411.00 to $381.00 and set a “buy” rating for the company in a report on Monday, April 22nd. Barclays lowered their price target on shares of Humana from $356.00 to $310.00 and set an “equal weight” rating on the stock in a report on Tuesday, April 2nd. Cantor Fitzgerald reduced their price objective on shares of Humana from $391.00 to $360.00 and set a “neutral” rating for the company in a research note on Thursday, April 25th. Finally, Royal Bank of Canada decreased their target price on shares of Humana from $415.00 to $353.00 and set an “outperform” rating for the company in a research report on Thursday, April 25th. Eleven analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. According to MarketBeat.com, Humana presently has an average rating of “Hold” and a consensus target price of $424.50.

Humana Stock Down 0.2 %

The firm has a market capitalization of $39.06 billion, a PE ratio of 20.18, a PEG ratio of 1.86 and a beta of 0.49. The business’s fifty day moving average price is $323.08 and its 200 day moving average price is $385.94. The company has a quick ratio of 1.67, a current ratio of 1.67 and a debt-to-equity ratio of 0.77.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share for the quarter, beating the consensus estimate of $6.12 by $1.11. Humana had a return on equity of 17.76% and a net margin of 1.82%. The company had revenue of $29.61 billion for the quarter, compared to the consensus estimate of $28.52 billion. During the same period last year, the business posted $9.38 EPS. The company’s revenue was up 10.7% on a year-over-year basis. On average, equities research analysts forecast that Humana Inc. will post 16.18 earnings per share for the current fiscal year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be issued a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.09%. The ex-dividend date is Friday, June 28th. Humana’s payout ratio is 22.04%.

Insider Transactions at Humana

In other Humana news, Director Jorge S. Mesquita purchased 545 shares of the firm’s stock in a transaction that occurred on Tuesday, February 20th. The shares were purchased at an average cost of $367.09 per share, for a total transaction of $200,064.05. Following the completion of the purchase, the director now directly owns 2,578 shares in the company, valued at $946,358.02. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Company insiders own 0.29% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in HUM. Rakuten Securities Inc. purchased a new stake in shares of Humana in the 4th quarter worth about $25,000. Gradient Investments LLC raised its position in shares of Humana by 200.0% during the 4th quarter. Gradient Investments LLC now owns 60 shares of the insurance provider’s stock worth $27,000 after purchasing an additional 40 shares during the last quarter. Cetera Trust Company N.A purchased a new stake in Humana in the 4th quarter valued at approximately $28,000. Private Wealth Management Group LLC purchased a new stake in Humana in the 4th quarter valued at approximately $32,000. Finally, Nvwm LLC grew its holdings in Humana by 41.0% during the 3rd quarter. Nvwm LLC now owns 86 shares of the insurance provider’s stock valued at $42,000 after buying an additional 25 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.